Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Center for Medical Weight Loss (CMWL) vs Lttl

vs+0.8000000000000114
Lttl
Graded #204

Lower grade

The verdict

Center for Medical Weight Loss (CMWL) takes it — 66.9/100 to 66.1/100, but only just.

Center for Medical Weight Loss (CMWL) grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Center for Medical Weight Loss (CMWL) runs a 100 percent online, physician-supervised GLP-1 program using compounded semaglutide and tirzepatide with flat any-dose pricing. Lttl is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCenter for Medical Weight Loss (CMWL) +20
76
56
Dose & formulationLttl +24
72
96
Clinical oversightCenter for Medical Weight Loss (CMWL) +2
78
76
Labs & monitoringEven
52
52
FulfillmentCenter for Medical Weight Loss (CMWL) +2
71
69
Contract termsEven
20
20
Center for Medical Weight Loss (CMWL) · left barLttl · right bar

The numbers

MetricCenter for Medical Weight Loss (CMWL)Lttl
WeighScore66.9/10066.1/100
GradeCC
Scorecard rank#171#204
Semaglutide$149/mo (all doses, compounded)$199/mo (all doses, compounded)
Tirzepatide$239/mo (all doses, compounded)$279/mo (all doses, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes

Strengths

  • Very competitive flat any-dose pricing (semaglutide from 116 dollars per month, tirzepatide from 159 dollars per month)
  • Established Center for Medical Weight Loss brand with physician supervision and clinical support
  • Fast 24-hour approvals and free three to five day shipping

Where it loses points

  • Some states are ineligible and the eligible-state list is not published
  • Compounding pharmacy is not named publicly
  • Lowest per-month prices require a three-month prepaid commitment
Lttl

Graded #204 · C

Strengths

  • Publishes the full price matrix — every medication, form and commitment length — on a public /plans page before checkout
  • Flat dose pricing: 'Same price at every dose,' so moving to a higher dose does not raise the monthly bill
  • States plainly that its compounded GLP-1s 'are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality'
  • Microdose line prices low-dose semaglutide or tirzepatide at $149/mo month-to-month for people sensitive to side effects
  • Oral ODT semaglutide offered for members who want to avoid injections

Where it loses points

  • Partner pharmacies are never named — the site refers only to 'a partner U.S. pharmacy' (a material disclosure gap for a YMYL purchase)
  • The advertised 'Plans start at $129/mo' is the 12-month prepay rate; true month-to-month is $199 semaglutide and $279 tirzepatide
  • No public list of states served — eligibility depends on where unnamed 'partner providers are licensed'
  • Site banner promises 'Prescribed and shipped within 48 hours' while the shipping policy states 2-5 business days to process plus 3-7 to deliver
  • Medications cannot be returned or refunded once they ship from the pharmacy

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard